glp-1 news today october 2025 Weight-Loss Drug Demonstration Begins July 2026 The New Health Consumer Mindset

Riding the Supplement Train Diets cool, but sometimes we need a bit of extra oomph

Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data

FDA pharmacovigilance review of FAERS reports for compounded GLP-1s has documented dosing errors, inadvertent overdoses, and product quality concerns linked specifically to the regulatory gap between compounded and brand-name product (Hoffman et al., 2025)

Cmo leer la etiqueta: No compares productos solo por el tamao del envase

The anti-fatigue mechanisms of carnosine operate through multiple pathways targeting muscle cells and metabolic function

FUNDING None NOTES None Acknowledgements Fig